AbelsonTaylor Group · 14 hours ago
Clinical Research Intern
Chicago, IL
Internship
Hybrid
Intern
$18/hr - $20/hrAbelsonTaylor Group is a company that focuses on health, wellness, and pharma products. They are seeking a Clinical Research Intern to support healthcare advertising by verifying claims against clinical literature and collaborating with other interns on a group project.
FitnessHealth Care
Responsibilities
Research and maintain references for assigned account(s) and organize all materials used as claim support in marketing materials
Review copy manuscripts from the writers and ensure every claim in the text is factual and supportable by high-quality references (e.g., randomized, controlled clinical trials, peer reviewed articles, guideline recommendations)
Prepare references to submit for use in med-reg review of marketing materials
Collaborate with fellow interns on a comprehensive, final project to feature in your professional portfolio
Qualification
Required
An expected 2026 graduate, or a rising senior (graduating 2027)
A dependable, self-motivated professional who thrives in a hybrid schedule, with optional remote work on Mondays and Fridays, and required on-site presence in our Chicago office Tuesdays through Thursdays
Able to multitask & complete tasks efficiently
Work well independently and as part of a team
Pursuing Science degree or have a scientific background, with a solid understanding of scientific, medical, and/or clinical text
Passionate for Science plus a curiosity about healthcare advertising
Self-starter, extremely organized and have a high degree of attention to detail
Seek out opportunities to learn the business of advertising and industry trends
Company
AbelsonTaylor Group
With AbelsonTaylor Group, ROI is what you’ll get. A Return On Imagination—through our expertise, insights, creativity, and strategy.
Founded in 1981
201-500 employees
Funding
Current Stage
Growth StageLeadership Team
K
Keith Stenlund
Chief Financial Officer
E
Eric Densmore
Senior Vice President Business Strategy
Recent News
2025-11-05
2024-04-07
Company data provided by crunchbase